Description Code
HIV, Pharmaceutical Products
Lamivudine 150 mg + Zidovudine 300 mg
Fixed-dose combination of Lamivudine and Zidovudine used in antiretroviral therapy for HIV-1.
Form: Film-coated tablet
Manufacturer: Cipla Ltd.
Country of Origin: India
| Composition | Lamivudine 150 mg + Zidovudine 300 mg |
|---|---|
| Pack Size | Strip of 10 tablets |
| Form | Film-coated tablet |
| Manufacturer | Cipla Ltd. |
| Country of Origin | India |
| Dosage Regimen | One tablet twice daily, or as prescribed |
| Usage Indications | HIV-1 infection treatment (part of ART regimens) |
| Administration Route | Oral – swallow with water, with or without food |
| Prescription Status | Rx required |
| Storage Conditions | Store below 25 °C; protect from moisture |
| Shelf Life | 24 months (typical) |
| Common Side Effects | anaemia, fatigue, headache, insomnia, nausea, rash |
| Precautions | liver/kidney function; caution in pregnancy; do not stop abruptly (risk flare), Monitor blood counts |
Related products
Colistimethate Sodium (1Million IU) Injection
AntibioticsA last-line injectable antibiotic used in serious, multidrug-resistant Gram-negative bacterial infections.
Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg + Efavirenz 600 mg
HIVFixed-dose combination tablet of Tenofovir Disoproxil Fumarate 300 mg, Emtricitabine 200 mg, and Efavirenz 600 mg, used for HIV-1 treatment.
Tenofovir Alafenamide 25 mg
HIVTenofovir Alafenamide 25 mg tablet used in the treatment of chronic hepatitis B (HBV) infection.
Reviews
There are no reviews yet.